[HTML][HTML] Library preparation for next generation sequencing: A review of automation strategies

JF Hess, TA Kohl, M Kotrová, K Rönsch… - Biotechnology …, 2020 - Elsevier
Next generation sequencing is in the process of evolving from a technology used for
research purposes to one which is applied in clinical diagnostics. Recently introduced high …

Adaptive immune receptor repertoire analysis

V Mhanna, H Bashour, K Lê Quý, P Barennes… - Nature Reviews …, 2024 - nature.com
B cell and T cell receptor repertoires compose the adaptive immune receptor repertoire
(AIRR) of an individual. The AIRR is a unique collection of antigen-specific receptors that …

Standardized next-generation sequencing of immunoglobulin and T-cell receptor gene recombinations for MRD marker identification in acute lymphoblastic …

M Brüggemann, M Kotrova, H Knecht, J Bartram… - Leukemia, 2019 - nature.com
Amplicon-based next-generation sequencing (NGS) of immunoglobulin (IG) and T-cell
receptor (TR) gene rearrangements for clonality assessment, marker identification and …

Circulating tumor DNA in lymphoma: principles and future directions

M Roschewski, D Rossi, DM Kurtz… - Blood Cancer …, 2022 - aacrjournals.org
Lymphomas are heterogeneous tumors with striking genetic diversity and variable outcomes
even within pathologic diagnoses. Treatment response assessment relies on radiologic and …

Quality control and quantification in IG/TR next-generation sequencing marker identification: protocols and bioinformatic functionalities by EuroClonality-NGS

H Knecht, T Reigl, M Kotrová, F Appelt, P Stewart… - Leukemia, 2019 - nature.com
Assessment of clonality, marker identification and measurement of minimal residual disease
(MRD) of immunoglobulin (IG) and T cell receptor (TR) gene rearrangements in lymphoid …

Validation of the EuroClonality-NGS DNA capture panel as an integrated genomic tool for lymphoproliferative disorders

JP Stewart, J Gazdova, N Darzentas, D Wren… - Blood …, 2021 - ashpublications.org
Current diagnostic standards for lymphoproliferative disorders include multiple tests for
detection of clonal immunoglobulin (IG) and/or T-cell receptor (TCR) rearrangements …

MRD assessment in multiple myeloma: progress and challenges

L Bertamini, M D'Agostino, F Gay - Current hematologic malignancy …, 2021 - Springer
Abstract Purpose of Review Over the last decade, the development of effective treatment
approaches for multiple myeloma (MM) has been associated with higher response rates and …

Liquid biopsy in hematological malignancies: current and future applications

D Talotta, M Almasri, C Cosentino, G Gaidano… - Frontiers in …, 2023 - frontiersin.org
The assessment of the cancer mutational profile is crucial for patient management,
stratification, and therapeutic decisions. At present, in hematological malignancies with a …

Droplet digital PCR quantification of mantle cell lymphoma follow-up samples from four prospective trials of the European MCL network

D Drandi, M Alcantara, I Benmaad, A Söhlbrandt… - …, 2020 - journals.lww.com
Minimal residual disease (MRD) has been increasingly investigated in mantle cell
lymphoma (MCL), including for individual therapeutic stratification and pre-emptive …

Proteogenomic analysis of the autoreactive B cell repertoire in blood and tissues of patients with Sjögren's syndrome

MGA Broeren, JJ Wang, G Balzaretti… - Annals of the …, 2022 - ard.bmj.com
Objective To comparatively analyse the aberrant affinity maturation of the antinuclear and
rheumatoid factor (RF) B cell repertoires in blood and tissues of patients with Sjögren's …